From: What women say about their dysmenorrhea: a qualitative thematic analysis
Participants with usable responses (N = 225) | Participants without usable responses (N = 537) | United States Census Data (%) [36] | ||
---|---|---|---|---|
Mean (SD) | Mean (SD) | p * | ||
Age, years | 34.8 (6.7) | 33.8 (6.4) | 0.09 | |
Dysmenorrhea symptom severity (0 “not severe at all” -10 “extremely severe”) | 6.7 (2.2) | 6.0 (2.1) | < 0.01 | |
n (%) | n (%) | p ** | ||
Hispanic Ethnicity | 26 (11.6) | 52 (9.7) | 0.44 | 17.6 |
Race | ||||
Asian/Pacific Islander | 12 (5.3) | 33 (6.2) | 0.66 | 5.6 |
Black/African American | 29 (12.9) | 79 (14.7) | 0.51 | 13.3 |
White/Caucasian | 166 (73.8) | 410 (76.4) | 0.45 | 77.1 |
Native American | 7 (3.1) | 8 (1.5) | 0.16 | 1.2 |
Bachelor’s degree or above | 82 (36.4) | 215 (40.0) | 0.35 | 29.3 |
Had diagnosed with conditions related to secondary dysmenorrhea | 49 (27.8) | 88 (16.4) | 0.08 | |
Uterine Fibroids | 22 (9.8) | 37 (6.9) | 0.17 | |
Endometriosis | 12 (5.3) | 31 (5.8) | 0.81 | |
Pelvic Inflammatory Disease | 11 (4.9) | 15 (2.5) | 0.14 | |
Others | 8 (3.6) | 19 (3.6) | 0.99 | |
Insured | 195 (86.7) | 457 (85.1) | 0.65 | |
Grew up in the United States | 210 (93.3) | 522 (97.2) | 0.01 | |
Diagnosed with a condition related to secondary dysmenorrhea | 50 (22.2) | 87 (16.2) | .05 | |
Used Medications for Dysmenorrhea in the Last 6 Months | 172 (76.4) | 385 (71.7) | 0.18 |